Endometriosis is characterized by the presence of endometrial and stromal tissue outside the uterine cavity. Endometriosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age between 20 and 40 years old Diagnosis of endometriosis Refusal to use other standard therapies Systemic estradiol >90 pg/ml during the first 4 days after the end of menstrual cycle. informed consent to entry Pelvic pain that has been present for at least three months
Exclusion criteria
Exclusion criteria: Diagnosis of secreting tumors previous history of Diabetes Melitus BMI>30 Taking hormones or inositol within 6 months before starting the study Using other drugs, especially (OCP and...) Any disease that interferes with the use of D-chiroinositol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pelvic pain. Timepoint: At the beginning of the study, one month after the start of treatment, 6 months after the start of treatment. Method of measurement: VAS score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pelvic pain. Timepoint: At the beginning of the study, one month after the start of treatment, 6 months after the start of treatment. Method of measurement: VAS score.;Dyspareunia. Timepoint: At the beginning of the study, one month after the start of treatment, 6 months after the start of treatment. Method of measurement: Vas score.;Dysmenorrhea. Timepoint: At the beginning of the study, one month after the start of treatment, 6 months after the start of treatment. Method of measurement: Vas score.;Dyschezia. Timepoint: At the beginning of the study, one month after the start of treatment, 6 months after the start of treatment. Method of measurement: Vas score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences